RAPID NUTRITION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.105 EUR | -2.78% |
|
+7.25% | -47.50% |
| Mar. 12 | Rapid Nutrition Completes Convertible Loan Facility Refinancing | MT |
| Feb. 20 | Rapid Nutrition Joins Osteoarthritis Prevention Study in US | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 3.454 | 1.871 | 2.344 | 2.344 | - |
| Enterprise Value (EV) 1 | 3.454 | 1.871 | 2.344 | 2.344 | 2.344 |
| P/E ratio | - | - | - | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 1.15 x | 0.63 x | 0.66 x | 0.59 x | 0.54 x |
| EV / Revenue | 1.15 x | 0.63 x | 0.66 x | 0.59 x | 0.54 x |
| EV / EBITDA | 9.56 x | -0.19 x | 3.01 x | 2.68 x | 2.46 x |
| EV / FCF | -12.8 x | - | 20.5 x | 11.1 x | 8.13 x |
| FCF Yield | -7.82% | - | 4.87% | 8.99% | 12.3% |
| Price to Book | -3.8 x | - | - | 2.86 x | 1.32 x |
| Nbr of stocks (in thousands) | 44.6 | 340 | 13,639 | 13,639 | - |
| Reference price 2 | 77.48 | 5.495 | 0.1719 | 0.1719 | 0.1719 |
| Announcement Date | 4/27/22 | 6/28/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.552 | 3 | 2.957 | 3.541 | 3.983 | 4.338 |
| EBITDA 1 | - | 0.3613 | -9.971 | 0.7791 | 0.8762 | 0.9543 |
| EBIT 1 | - | 0.2381 | - | 0.6246 | 0.7217 | 0.7998 |
| Operating Margin | - | 7.94% | - | 17.64% | 18.12% | 18.44% |
| Earnings before Tax (EBT) | - | - | - | - | - | - |
| Net income | -4.576 | - | - | - | - | - |
| Net margin | -100.52% | - | - | - | - | - |
| EPS | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -0.27 | - | 0.1141 | 0.2107 | 0.2883 |
| FCF margin | - | -9% | - | 3.22% | 5.29% | 6.65% |
| FCF Conversion (EBITDA) | - | - | - | 14.65% | 24.05% | 30.21% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/1/21 | 4/27/22 | 6/28/23 | - | - | - |
1AUD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -0.27 | - | 0.11 | 0.21 | 0.29 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets | - | - | - | - | - | - |
| Book Value Per Share | - | -20.40 | - | - | 0.0600 | 0.1300 |
| Cash Flow per Share 2 | - | -6.100 | - | 2.000 | 3.000 | 3.000 |
| Capex 1 | - | 0.01 | - | 0.02 | 0.02 | 0.02 |
| Capex / Sales | - | 0.33% | - | 0.42% | 0.38% | 0.35% |
| Announcement Date | 4/1/21 | 4/27/22 | 6/28/23 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1719
AUD
Average target price
1,649
AUD
Spread / Average Target
+959,248.54%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -47.50% | 1.53M | |
| +8.20% | 7.78B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -13.13% | 3.44B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
- Stock Market
- Equities
- ALRPD Stock
- Financials Rapid Nutrition Plc
